Study summary
The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:
1. Does blood flow restriction training improve neuromuscular function compared with conventional training?
2. Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?
Researchers will compare participants receiving blood flow restriction training with participants performing conventional training to determine whether blood flow restriction training provides additional benefits. Participants will complete an 8-week training program and undergo assessments before and after the intervention, including muscle function tests, physical performance tests, body composition measurements, and physiological response evaluations.
Eligibility
Inclusion Criteria:
1. Adults aged 18 to 25 years.
2. Current artistic jump rope athletes with at least 2 years of regular artistic jump rope training experience.
3. Participants who are able to perform artistic jump rope skills and complete all study-related assessments and training procedures.
4. Participants who are physically healthy and have no medical conditions that may interfere with exercise testing or blood flow restriction training.
5. Participants who have no acute or chronic musculoskeletal injuries affecting the upper limbs, lower limbs, or trunk.
6. Participants who voluntarily agree to participate and provide written informed consent before enrollment.
Exclusion Criteria:
1. Participants younger than 18 years or older than 25 years.
2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation disorders, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise safety.
3. Presence of acute or chronic musculoskeletal injuries, including injuries involving muscles, joints, ligaments, tendons, or bones, that prevent safe completion of study procedures.
4. Significant pain, severe fatigue, insufficient recovery, poor sleep condition, or other health conditions that may affect exercise performance or participant safety.
5. Use of medications, nutritional supplements, or sports supplements within the previous week that may influence cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance.
6. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
7. Inability to understand the study procedures or inability to complete required assessments, including physical performance tests, blood flow restriction training, or blood lactate testing.
8. Refusal to participate in blood flow restriction training or withdrawal of informed consent during the study.
Exclusion Criteria:
* 1\. Age younger than 18 years or older than 25 years. 2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation abnormalities, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise testing or blood flow restriction training safety.
3\. Current acute or chronic injuries involving muscles, joints, ligaments, tendons, or bones that prevent safe completion of study procedures.
4\. Severe fatigue, poor recovery status, significant pain, insufficient sleep, or other conditions that may influence exercise performance or participant safety.
5\. Use of medications, nutritional supplements, or sports supplements that may affect cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance within the previous week.
6\. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
7\. Inability or unwillingness to complete study assessments, blood flow restriction training, blood lactate testing, or other required procedures.
8\. Withdrawal of consent or inability to comply with the study protocol during the intervention period.